Insider Trading disclosures for SELLAS Life Sciences Group Inc

The latest disclosure was made by Angelos M. Stergiou in SELLAS Life Sciences Group Inc where a trade of 257,000 Common Stock done was reported to US exchanges on Jan. 10, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	257,000	615,132 (12%)	5%		0	Common Stock
Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	22,900 (0%)	0%		0	Common Stock
Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	23,082 (0%)	0%		0	Common Stock
David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	22,900 (0%)	0%		0	Common Stock
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	22,900 (0%)	0%		0	Common Stock
Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	243,900	859,032 (16%)	4%		0	Common Stock
Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	385,750	385,750	-		-	Stock Option (Right to Buy)
Dragan Cicic	SVP, Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	113,000	228,328 (4%)	2%		0	Common Stock
Dragan Cicic	SVP, Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	81,300	309,628 (6%)	1%		0	Common Stock
Dragan Cicic	SVP, Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	169,500	169,500	-		-	Stock Option (Right to Buy)
John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	113,000	217,762 (4%)	2%		0	Common Stock
John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	81,300	299,062 (5%)	1%		0	Common Stock
John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	169,500	169,500	-		-	Stock Option (Right to Buy)
Katherine Bach Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	18,500	18,500	-		-	Stock Option (Right to Buy)
Katherine Bach Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	12,500	21,000 (0%)	0%		0	Common Stock
Burns John T.	CFO	Other type of transaction at price $ 1.13 per share.	04 Dec 2024	7,165	104,762 (2%)	0%	1.1	8,096	Common Stock
Cicic Dragan	SVP, Chief Development Officer	Other type of transaction at price $ 1.13 per share.	04 Dec 2024	8,256	115,328 (2%)	0%	1.1	9,329	Common Stock
M. Angelos Stergiou	Director, President and CEO	Other type of transaction at price $ 1.13 per share.	04 Dec 2024	28,289	358,132 (7%)	0%	1.1	31,967	Common Stock
Van Nostrand L. Robert	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
Bach Katherine Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
Katherine Kalin Bach	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	6,000	8,500 (0%)	0%		0	Common Stock
Burns T. John	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	75,000	75,000	-		-	Stock Option (Right to Buy)
Robert Van Nostrand L.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	6,000	10,400 (0%)	0%		0	Common Stock
A. David Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	6,000	10,582 (0%)	0%		0	Common Stock
A. David Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
Wood A. Barbara	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	35,000	117,225 (2%)	0%		0	Common Stock
Wasman Jane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
M. Angelos Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	238,500	238,500	-		-	Stock Option (Right to Buy)
Angelos Stergiou M.	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	159,000	376,421 (7%)	3%		0	Common Stock
John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	47,000	101,927 (2%)	0%		0	Common Stock
Francomano Robert	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	30,000	30,000	-		-	Stock Option (Right to Buy)
Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	6,000	10,400 (0%)	0%		0	Common Stock
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	6,000	10,400 (0%)	0%		0	Common Stock
Wood A. Barbara	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	50,000	50,000	-		-	Stock Option (Right to Buy)
Robert Francomano	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	20,000	40,918 (0%)	0%		0	Common Stock
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
A. Wood Barbara	EVP, Gen. Counsel, Corp. Sec.	Other type of transaction at price $ 1.08 per share.	06 Dec 2023	4,119	82,225 (1%)	0%	1.1	4,449	Class A Common Stock
Francomano Robert	Chief Commercial Officer	Other type of transaction at price $ 1.08 per share.	06 Dec 2023	1,082	20,918 (0%)	0%	1.1	1,169	Class A Common Stock
John T. Burns	CFO	Other type of transaction at price $ 1.08 per share.	06 Dec 2023	2,929	54,927 (1%)	0%	1.1	3,163	Class A Common Stock
Angelos M. Stergiou	Director, President and CEO	Other type of transaction at price $ 1.08 per share.	06 Dec 2023	12,268	217,421 (4%)	0%	1.1	13,249	Class A Common Stock
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	20,000	76,344 (1%)	0%		0	Common Stock
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	80,000	80,000	-		-	Stock Option (Right to Buy)
Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	2,500	4,400 (0%)	0%		0	Common Stock
Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	9,500	9,500	-		-	Stock Option (Right to Buy)
David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	9,500	9,500	-		-	Stock Option (Right to Buy)
David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	2,500	4,582 (0%)	0%		0	Common Stock
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	2,500	4,400 (0%)	0%		0	Common Stock
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	9,500	9,500	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	9,500	9,500	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	2,500	4,400 (0%)	0%		0	Common Stock
Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	217,500	217,500	-		-	Stock Option (Right to Buy)
Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	58,000	219,689 (4%)	1%		0	Common Stock
John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	20,000	49,347 (0%)	0%		0	Common Stock
John T. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	75,000	75,000	-		-	Stock Option Right to Buy)
Robert Francomano	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	45,000	45,000	-		-	Stock Option (Right to Buy)
Robert Francomano	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	12,000	12,000 (0%)	0%		0	Common Stock
Katherine Bach Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	9,500	9,500	-		-	Stock Option (Right to Buy)
Katherine Bach Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2023	2,500	2,500 (0%)	0%		0	Common Stock
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Sale of securities on an exchange or to another person at price $ 2.59 per share.	05 Dec 2022	2,153	56,344 (1%)	0%	2.6	5,576	Class A Common Stock
Angelos M. Stergiou	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 2.61 per share.	05 Dec 2022	6,494	161,689	-	2.6	16,938	Class A Common Stock
John T. Burns	Senior VP, Finance & CAO	Sale of securities on an exchange or to another person at price $ 2.59 per share.	05 Dec 2022	1,159	29,347 (0%)	0%	2.6	3,002	Class A Common Stock
Katherine Bach Kalin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Aug 2022	19,000	19,000	-		-	Stock Option (Right to Buy)
Robert Francomano	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2022	100,000	100,000	-		-	Stock Option (Right to Buy)
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	13,000	55,028 (1%)	0%		0	Common Stock
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	48,750	48,750	-		-	Stock Option (Right to Buy)
Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	1,900	1,900 (0%)	0%		0	Common Stock
Jane Wasman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	7,125	7,125	-		-	Stock Option (Right to Buy)
David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	1,900	2,082 (0%)	0%		0	Common Stock
David A. Scheinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	7,125	7,125	-		-	Stock Option (Right to Buy)
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	7,125	7,125	-		-	Stock Option (Right to Buy)
John Varian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	1,900	1,900 (0%)	0%		0	Common Stock
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	7,125	7,125	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	1,900	1,900 (0%)	0%		0	Common Stock
Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	165,000	165,000	-		-	Stock Option (Right to Buy)
Angelos M. Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	44,000	165,167 (3%)	0%		0	Common Stock
John T. Burns	Senior VP, Finance & CAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	36,000	36,000	-		-	Stock Option (Right to Buy)
John T. Burns	Senior VP, Finance & CAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	9,600	27,244 (0%)	0%		0	Common Stock
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	35,000	35,000 (0%)	0%		0	Common Stock
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	25,000	25,000	-		-	Stock Option (Right to Buy)
Jane Wasman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	6,500	6,500	-		-	Stock Option (Right to Buy)
David A. Scheinberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	6,500	6,500	-		-	Stock Option (Right to Buy)
John Varian	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	6,500	6,500	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	6,500	6,500	-		-	Stock Option (Right to Buy)
Angelos Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	70,000	70,000	-		-	Stock Option (Right to Buy)
Angelos Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	95,000	95,000 (1%)	1%		0	Common Stock
John T. Burns	VP, Finance & Corp Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	15,000	15,000 (0%)	0%		0	Common Stock
John T. Burns	VP, Finance & Corp Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	10,000	10,000	-		-	Stock Option (Right to Buy)
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	165,000	165,000	-		-	Stock Option (Right to Buy)
Jane Wasman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	25,000	25,000	-		-	Stock Option (Right to Buy)
Stephen F. Ghiglieri	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	25,000	25,000	-		-	Stock Option (Right to Buy)
David A. Scheinberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	25,000	25,000	-		-	Stock Option (Right to Buy)
John Varian	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	25,000	25,000	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	25,000	25,000	-		-	Stock Option (Right to Buy)
Angelos Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	425,000	425,000	-		-	Stock Option (Right to Buy)
John T. Burns	VP, Finance & Corp Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	90,000	90,000	-		-	Stock Option (Right to Buy)
Nicholas J. Sarlis	Chief Medical Officer and SVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2019	50,000	50,000	-		-	Stock Option (Right to Buy)
Angelos Stergiou	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 1.25 per share.	31 Dec 2018	23,277	426,858 (1%)	0%	1.3	29,189	Common Stock
Fabio Lopez	Other	Other type of transaction at price $ 0.00 per share.	24 Sep 2018	325,799	0 (0%)	1%		0	Common Stock
Fabio Lopez	Other	Other type of transaction at price $ 0.00 per share.	24 Sep 2018	1,521,863	0 (0%)	7%		0	Common Stock
Fabio Lopez	Other	Other type of transaction at price $ 0.00 per share.	24 Sep 2018	676,324	0 (0%)	3%		0	Common Stock
Jane Wasman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2018	5,500	5,500	-		-	Stock Option (Right to Buy)
Stephen F. Ghiglieri	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2018	5,500	5,500	-		-	Stock Option (Right to Buy)
David A. Scheinberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2018	5,500	5,500	-		-	Stock Option (Right to Buy)
John Varian	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2018	5,500	5,500	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2018	5,500	5,500	-		-	Stock Option (Right to Buy)
Fabio Lopez	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2018	5,500	5,500	-		-	Stock Option (Right to Buy)
Gene Mack	CFO and Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Apr 2018	40,000	40,000	-		-	Stock Option (Right to Buy)
Barbara A. Wood	EVP, Gen. Counsel, Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2018	50,000	50,000	-		-	Stock Option (Right to Buy)
Jane Wasman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	11,000	11,000	-		-	Stock Option (Right to Buy)
Stephen F. Ghiglieri	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	11,000	11,000	-		-	Stock Option (Right to Buy)
David A. Scheinberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	11,000	11,000	-		-	Stock Option (Right to Buy)
Gregory Torre	CRO and SVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	30,000	30,000	-		-	Stock Option (Right to Buy)
John Varian	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	11,000	11,000	-		-	Stock Option (Right to Buy)
Robert L. Van Nostrand	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	11,000	11,000	-		-	Stock Option (Right to Buy)
Angelos Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	95,000	95,000	-		-	Stock Option (Right to Buy)
Nicholas J. Sarlis	Chief Medical Officer and SVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	70,000	70,000	-		-	Stock Option (Right to Buy)
Fabio Lopez	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2018	11,000	11,000	-		-	Stock Option (Right to Buy)
David A. Scheinberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Dec 2017	9,107	9,107 (0%)	0%		0	Common Stock
Angelos Stergiou	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Dec 2017	450,135	450,135 (7%)	7%		0	Common Stock
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.38 per share.	10 Oct 2017	17,130	42,918 (0%)	0%	0.4	6,509	Common Stock
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.38 per share.	10 Oct 2017	13,814	36,039 (0%)	0%	0.4	5,249	Common Stock
Mary Ann Gray	None	Grant, award, or other acquisition of securities at price $ 0.38 per share.	10 Oct 2017	15,472	39,167 (0%)	0%	0.4	5,879	Common Stock
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.38 per share.	10 Oct 2017	12,708	31,339 (0%)	0%	0.4	4,829	Common Stock
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.38 per share.	10 Oct 2017	20,997	56,950 (0%)	0%	0.4	7,979	Common Stock
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.38 per share.	10 Oct 2017	15,472	38,154 (0%)	0%	0.4	5,879	Common Stock
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 0.38 per share.	10 Oct 2017	14,366	34,690 (0%)	0%	0.4	5,459	Common Stock
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2017	5,000	5,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	28 Jun 2017	10,924	25,788 (0%)	0%	0.6	6,445	Common Stock
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	28 Jun 2017	8,809	22,225 (0%)	0%	0.6	5,197	Common Stock
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2017	5,000	5,000	-		-	Stock Option (right to buy)
Mary Ann Gray	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	28 Jun 2017	9,866	23,695 (0%)	0%	0.6	5,821	Common Stock
Mary Ann Gray	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2017	5,000	5,000	-		-	Stock Option (right to buy)
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	28 Jun 2017	8,104	18,631 (0%)	0%	0.6	4,781	Common Stock
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2017	5,000	5,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2017	5,000	5,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	28 Jun 2017	13,390	35,953 (0%)	0%	0.6	7,900	Common Stock
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	28 Jun 2017	9,866	22,682 (0%)	0%	0.6	5,821	Common Stock
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2017	5,000	5,000	-		-	Stock Option (right to buy)
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2017	5,000	5,000	-		-	Stock Option (right to buy)
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	28 Jun 2017	9,161	20,114 (0%)	0%	0.6	5,405	Common Stock
Rudolph Nisi	None	Sale of securities on an exchange or to another person at price $ 0.55 per share.	20 Jun 2017	500	14,864 (0%)	0%	0.5	273	Common Stock
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	10 Apr 2017	10,927	15,364 (0%)	0%	0.6	6,447	Common Stock
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	10 Apr 2017	9,865	13,416 (0%)	0%	0.6	5,820	Common Stock
Mary Ann Gray	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	10 Apr 2017	8,815	13,829 (0%)	0%	0.6	5,201	Common Stock
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	10 Apr 2017	8,107	10,527 (0%)	0%	0.6	4,783	Common Stock
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	10 Apr 2017	13,394	22,563 (0%)	0%	0.6	7,902	Common Stock
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	10 Apr 2017	9,870	12,816 (0%)	0%	0.6	5,823	Common Stock
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 0.59 per share.	10 Apr 2017	8,638	10,953 (0%)	0%	0.6	5,096	Common Stock
Thomas J. Knapp	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2017	10,000	10,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 1.98 per share.	20 Jan 2017	3,262	4,437 (0%)	0%	2.0	6,459	Common Stock
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 1.98 per share.	20 Jan 2017	3,051	3,551 (0%)	0%	2.0	6,041	Common Stock
Mary Ann Gray	None	Grant, award, or other acquisition of securities at price $ 1.98 per share.	20 Jan 2017	2,525	5,004 (0%)	0%	2.0	5,000	Common Stock
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 1.98 per share.	20 Jan 2017	2,420	2,420 (0%)	0%	2.0	4,792	Common Stock
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 1.98 per share.	20 Jan 2017	3,998	9,169 (0%)	0%	2.0	7,916	Common Stock
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 1.98 per share.	20 Jan 2017	2,946	2,946 (0%)	0%	2.0	5,833	Common Stock
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 1.98 per share.	20 Jan 2017	2,525	2,525 (0%)	0%	2.0	5,000	Common Stock
Thomas J. Knapp	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2017	5,000	5,000	-		-	Stock Option (right to buy)
Bijan Nejadnik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2017	30,000	30,000	-		-	Stock Option (right to buy)
John T. Burns	Vice President, Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2017	15,000	15,000	-		-	Stock Option (right to buy)
Stephen F. Ghiglieri	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2016	1,000,000	1,000,000	-		-	Stock Option (right to buy)
Thomas J. Knapp	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Oct 2016	102,000	102,000	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2016	100,000	100,000	-		-	Stock Option (right to buy)
Mary Ann Gray	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2016	100,000	100,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2016	100,000	100,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2016	100,000	100,000	-		-	Stock Option (right to buy)
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2016	100,000	100,000	-		-	Stock Option (right to buy)
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2016	100,000	100,000	-		-	Stock Option (right to buy)
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2016	100,000	100,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	President & CEO	Other type of transaction at price $ 0.00 per share.	01 Jul 2016	8,503	439,978	-		-	Common Stock
Bijan Nejadnik	Chief Medical Officer	Other type of transaction at price $ 0.00 per share.	01 Jul 2016	8,503	8,503	-		-	Common Stock
John T. Burns	Principal Accounting Officer	Other type of transaction at price $ 0.00 per share.	01 Jul 2016	8,503	10,899	-		-	Common Stock
Ryan Dunlap	Former Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	31,250	49,952	-		-	Common Stock
Ryan Dunlap	Former Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	31,250	95,625	-		-	Stock Option
Ryan Dunlap	Former Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	65,625	115,577	-		-	Common Stock
Ryan Dunlap	Former Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	65,625	30,000	-		-	Stock Option
Ryan Dunlap	Former Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	30,000	145,577	-		-	Common Stock
Ryan Dunlap	Former Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	30,000	0	-		-	Stock Option
Ryan Dunlap	Former Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Jun 2016	126,875	18,702	-		-	Common Stock
Mary Ann Gray	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Apr 2016	200,000	200,000	-		-	Stock Option (right to buy)
John T. Burns	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2016	75,000	75,000	-		-	Stock Option (right to buy)
Thomas J. Knapp	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Dec 2015	225,000	225,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Dec 2015	1,250,000	1,250,000	-		-	Stock Option (right to buy)
Bijan Nejadnik	Executive VP and CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Dec 2015	50,000	50,000	-		-	Stock Option (right to buy)
Bijan Nejadnik	Executive VP and CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Oct 2015	350,000	350,000	-		-	Stock Option (right to buy)
Thomas J. Knapp	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2015	40,000	40,000	-		-	Stock Option (right to buy)
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jun 2015	100,000	100,000	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jun 2015	100,000	100,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jun 2015	100,000	100,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jun 2015	100,000	100,000	-		-	Stock Option (right to buy)
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jun 2015	100,000	100,000	-		-	Stock Option (right to buy)
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jun 2015	100,000	100,000	-		-	Stock Option (right to buy)
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jun 2015	100,000	100,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2015	550,000	550,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	Director, President & CEO	Other type of transaction at price $ 0.00 per share.	16 Jan 2015	3,846	415,972	-		-	Common Stock
Ryan Dunlap	VP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2015	125,000	125,000	-		-	Stock Option (right to buy)
Ryan Dunlap	VP, Chief Financial Officer	Other type of transaction at price $ 0.00 per share.	16 Jan 2015	3,846	11,650	-		-	Common Stock
Margaret Kivinski	VP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2015	50,000	50,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Gift of securities by or to the insider at price $ 0.00 per share.	31 Dec 2014	10,000	85,447	-		-	Common Stock
Mark W. Schwartz	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2014	200,000	200,000	-		-	Stock Option (right to buy)
Margaret Kivinski	VP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jul 2014	200,000	200,000	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2014	2,461	116,225	-		-	Common Stock
Brian L. Hamilton	EVP, Chief Medical Officer	Other type of transaction at price $ 0.00 per share.	30 Jun 2014	2,461	2,461	-		-	Common Stock
Mark W. Schwartz	EVP, Chief Operating Officer	Other type of transaction at price $ 0.00 per share.	30 Jun 2014	2,461	412,126	-		-	Common Stock
Ryan Dunlap	VP, Chief Financial Officer	Other type of transaction at price $ 0.00 per share.	30 Jun 2014	2,461	7,804	-		-	Common Stock
Irving M. Einhorn	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Apr 2014	100,000	100,000	-		-	Stock Option (right to buy)
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Feb 2014	100,000	0	-		-	Stock Option (right to buy)
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Feb 2014	50,000	0	-		-	Stock Option (right to buy)
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Feb 2014	37,500	12,500	-		-	Stock Option (right to buy)
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Feb 2014	100,000	150,000	-		-	Common Stock
Richard Chin	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	12 Feb 2014	187,500	0	-		-	Common Stock
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Feb 2014	50,000	50,000	-		-	Common Stock
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Feb 2014	37,500	187,500	-		-	Common Stock
Rudolph Nisi	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Feb 2014	20,000	23,500	-		-	Common Stock
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	260,000	-		-	Common Stock
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	310,000	-		-	Common Stock
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	210,000	-		-	Common Stock
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	0	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Feb 2014	300,000	10,000	-		-	Common Stock
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	60,000	-		-	Common Stock
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	0	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	0	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	100,000	160,000	-		-	Common Stock
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	50,000	0	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2014	100,000	0	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	100,000	0	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	30 Jan 2014	250,000	17,974	-		-	Common Stock
Sanford J. Hillsberg	None		30 Jan 2014	50,000	0	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	100,000	0	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	50,000	267,974	-		-	Common Stock
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	200,000	217,974	-		-	Common Stock
Sanford J. Hillsberg	None	Gift of securities by or to the insider at price $ 0.00 per share.	30 Jan 2014	15,000	95,447	-		-	Common Stock
Richard Chin	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	30 Jan 2014	50,000	25,000	-		-	Common Stock
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	25,000	75,000	-		-	Common Stock
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	25,000	0	-		-	Stock Option (right to buy)
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	50,000	0	-		-	Stock Option (right to buy)
Richard Chin	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	30 Jan 2014	25,000	0	-		-	Common Stock
Richard Chin	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2014	50,000	50,000	-		-	Common Stock
Mark W. Schwartz	EVP & Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	30 Jan 2014	100,000	409,665	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	50,000	0	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	100,000	153,500	-		-	Common Stock
Rudolph Nisi	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jan 2014	250,000	3,500	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	50,000	53,500	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	50,000	203,500	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	50,000	253,500	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	100,000	0	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	50,000	0	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2014	50,000	0	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	200,000	788,654	-		-	Common Stock
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	200,000	200,000	-		-	Stock Option
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	50,000	0	-		-	Stock Option
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	100,000	0	-		-	Stock Option
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	100,000	263,764	-		-	Common Stock
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	324,890	588,654	-		-	Common Stock
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	50,000	163,764	-		-	Common Stock
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	324,890	25,110	-		-	Stock Option
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	121,875	423,173	-		-	Stock Option
Mark J. Ahn	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Jan 2014	796,765	113,764	-		-	Common Stock
Mark J. Ahn	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2014	121,875	918,529	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2014	50,000	155,000	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2014	50,000	0	-		-	Stock Option (right to buy)
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Jan 2014	150,000	5,000	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2014	100,000	0	-		-	Stock Option (right to buy)
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2014	100,000	105,000	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2014	50,000	255,000	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2014	200,000	205,000	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Jan 2014	250,000	5,000	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2014	50,000	0	-		-	Stock Option (right to buy)
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2014	200,000	0	-		-	Stock Option (right to buy)
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Jan 2014	200,000	5,000	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2014	200,000	205,000	-		-	Common Stock
Steven A. Kriegsman	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2014	200,000	0	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Jan 2014	200,000	110,447	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jan 2014	100,000	203,500	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jan 2014	100,000	0	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jan 2014	100,000	103,500	-		-	Common Stock
Rudolph Nisi	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jan 2014	100,000	0	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Jan 2014	200,000	3,500	-		-	Common Stock
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jan 2014	200,000	334,873	-		-	Common Stock
Sanford J. Hillsberg	None	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	14 Jan 2014	24,426	310,447	-		-	Common Stock
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jan 2014	200,000	0	-		-	Stock Option
Mark J. Ahn	Director, President & CEO	Other type of transaction at price $ 0.00 per share.	31 Dec 2013	5,656	113,764	-		-	Common Stock
Mark W. Schwartz	EVP & Chief Operating Officer	Other type of transaction at price $ 0.00 per share.	31 Dec 2013	5,656	509,665	-		-	Common Stock
Ryan Dunlap	Principal Accounting Officer	Other type of transaction at price $ 0.00 per share.	31 Dec 2013	2,728	5,343	-		-	Common Stock
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	200,000	200,000	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	200,000	200,000	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	600,000	600,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	200,000	200,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	200,000	200,000	-		-	Stock Option (right to buy)
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	200,000	200,000	-		-	Stock Option (right to buy)
Brian L. Hamilton	EVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	300,000	300,000	-		-	Stock Option (right to buy)
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	200,000	200,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	300,000	300,000	-		-	Stock Option (right to buy)
Ryan Dunlap	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Nov 2013	150,000	150,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2013	50,000	0	-		-	Stock Option
Sanford J. Hillsberg	None	Gift of securities by or to the insider at price $ 0.00 per share.	12 Nov 2013	37,001	93,375	-		-	Common Stock
Sanford J. Hillsberg	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2013	50,000	143,375	-		-	Common Stock
Sanford J. Hillsberg	None	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	12 Nov 2013	8,592	134,873	-		-	Common Stock
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Oct 2013	2,630	17,974	-		-	Common Stock
Mark W. Schwartz	EVP, Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Oct 2013	7,349	504,009	-		-	Common Stock
Mark J. Ahn	Director, President & CEO	Other type of transaction at price $ 0.00 per share.	30 Jun 2013	7,862	108,108	-		-	Common Stock, par value $0.0001
Mark W. Schwartz	EVP, Chief Operating Officer	Other type of transaction at price $ 0.00 per share.	30 Jun 2013	7,862	496,660	-		-	Common Stock, par value $0.0001
Ryan Dunlap	Principal Accounting Officer	Other type of transaction at price $ 0.00 per share.	30 Jun 2013	1,369	2,615	-		-	Common Stock, par value $0.0001
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2013	9,344	145,720	-		-	Common Stock
Mark W. Schwartz	EVP, Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2013	26,110	488,798	-		-	Common Stock
William L. Ashton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Apr 2013	100,000	100,000	-		-	Stock Option (right to buy)
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	50,000	50,000	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	50,000	50,000	-		-	Stock Option (right to buy)
Rosemary Mazanet	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	450,000	450,000	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	650,000	650,000	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President & CEO	Other type of transaction at price $ 0.00 per share.	29 Jan 2013	7,668	100,246	-		-	Common Stock, par value $0.0001
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	50,000	50,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	50,000	50,000	-		-	Stock Option (right to buy)
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	50,000	50,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	EVP, Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	250,000	250,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	EVP, Chief Operating Officer	Other type of transaction at price $ 0.00 per share.	29 Jan 2013	7,668	462,688	-		-	Common Stock, par value $0.0001
Ryan Dunlap	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2013	40,000	40,000	-		-	Stock Option (right to buy)
Ryan Dunlap	Principal Accounting Officer	Other type of transaction at price $ 0.00 per share.	29 Jan 2013	1,246	1,246	-		-	Common Stock, par value $0.0001
Sanford J. Hillsberg	None	Gift of securities by or to the insider at price $ 0.00 per share.	02 Nov 2012	20,000	136,376	-		-	Common Stock
Mark J. Ahn	Director, President & CEO	Other type of transaction at price $ 0.00 per share.	10 Jul 2012	31,289	92,578	-		-	Common Stock, par value $0.0001
Rosemary Mazanet	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2012	150,000	150,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2012	31,966	156,376	-		-	Common Stock
Mark W. Schwartz	EVP Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2012	89,322	439,907	-		-	Common Stock, par value $0.0001
Mark W. Schwartz	EVP Chief Operating Officer	Other type of transaction at price $ 0.00 per share.	15 Jun 2012	21,902	461,809	-		-	Common Stock, par value $0.0001
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2012	50,000	50,000	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2012	50,000	50,000	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2012	400,000	400,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2012	50,000	50,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2012	50,000	50,000	-		-	Stock Option (right to buy)
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2012	50,000	50,000	-		-	Stock Option (right to buy)
Mark W. Schwartz	EVP Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2012	200,000	200,000	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President & CEO	Other type of transaction at price $ 0.00 per share.	31 Dec 2011	31,289	61,289	-		-	Common Stock, par value $.0001
Mark W. Schwartz	EVP Chief Operating Officer	Other type of transaction at price $ 0.00 per share.	31 Dec 2011	12,924	350,585	-		-	Common Stock, par value $.0001
Mark J. Ahn	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Dec 2011	10,000	20,000	-		-	Common Stock, par value $.0001
Kwang Lee	Principal Accounting Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Dec 2011	5,000	5,000	-		-	Common Stock, par value $.0001
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2011	200,000	200,000	-		-	Stock Option (right to buy)
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2011	50,000	50,000	-		-	Stock Option (right to buy)
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2011	200,000	200,000	-		-	Stock Option (right to buy)
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2011	100,000	100,000	-		-	Stock Option (right to buy)
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2011	25,000	25,000	-		-	Stock Option (right to buy)
Pamela Pavco	Other	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Sep 2011	150,000	150,000	-		-	Stock Option (right to buy)
Anastasia Khvorova	Other	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Sep 2011	76,923	137,482	-		-	Common Stock
Mark W. Schwartz	EVP Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Sep 2011	250,000	250,000	-		-	Stock Option (right to buy)
Mark J. Ahn	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	20 Apr 2011	10,000	10,000	-		-	Common Stock, par value $.0001
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Apr 2011	120,838	126,838	-		-	Common Stock
Mark W. Schwartz	EVP, Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Apr 2011	330,872	330,872	-		-	Common Stock
Robert E. Kennedy	Vice President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Apr 2011	30,000	30,000	-		-	Stock Option
Robert E. Kennedy	Vice President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Apr 2011	374,288	374,288	-		-	Common Stock
Robert E. Kennedy	Vice President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Apr 2011	2,430	376,718	-		-	Common Stock
Robert E. Kennedy	Vice President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Apr 2011	2,576	379,294	-		-	Common Stock
Mark J. Ahn	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2011	100,000	100,000	-		-	Stock Option
Mark J. Ahn	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2011	525,000	525,000	-		-	Stock Option
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	100,000	100,000	-		-	Stock Option
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	200,000	200,000	-		-	Stock Option
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	100,000	100,000	-		-	Stock Option
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	100,000	100,000	-		-	Stock Option
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	100,000	100,000	-		-	Stock Option
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	100,000	100,000	-		-	Stock Option
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	100,000	100,000	-		-	Stock Option
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2011	100,000	100,000	-		-	Stock Option
Noah D. Beerman	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2011	77,587	92,994	-		-	Common Stock
Pamela Pavco	VP of Pharmaceutical Devlpmt	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2011	33,563	44,940	-		-	Common Stock
Ramani Varanasi	VP Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2011	29,925	41,083	-		-	Common Stock
Anastasia Khvorova	Chief Science Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2011	43,053	60,559	-		-	Common Stock
Amy Tata	Principlw Acctg Officer & Cont	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2011	14,065	14,065	-		-	Common Stock
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jan 2011	50,000	50,000	-		-	Stock Option
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jan 2011	50,000	50,000	-		-	Stock Option
Mark J. Ahn	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jan 2011	50,000	50,000	-		-	Stock Option
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jan 2011	50,000	50,000	-		-	Stock Option
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jan 2011	50,000	50,000	-		-	Stock Option
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jan 2011	50,000	50,000	-		-	Stock Option
Ramani Varanasi	VP Business Development	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Jul 2010	5,000	5,558	-		-	Common Stock
Ramani Varanasi	VP Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2010	5,600	11,158	-		-	Common Stock
Pamela Pavco	VP of Pharmaceutical Devlpmt.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2010	5,000	11,377	-		-	Common Stock
Anastasia Khvorova	Chief Science Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2010	10,000	17,506	-		-	Common Stock
Noah D. Beerman	Director, CEO and President	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	09 Jul 2010	10,000	15,407	-		-	Common Stock
Ramani Varanasi	VP Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2010	5,000	10,558	-		-	Common Stock
Pamela Pavco	VP of Pharmaceutical Devlpmt.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Apr 2010	15,000	15,000	-		-	Stock Option
Ramani Varanasi	VP Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Apr 2010	15,000	15,000	-		-	Stock Option
Anastasia Khvorova	Chief Science Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Apr 2010	15,000	15,000	-		-	Stock Option
Konstantinos Andrikopoulos	VP, Legal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Apr 2010	15,000	15,000	-		-	Stock Option
Dmitry Samarsky	VP, Technology Development		31 Mar 2010	4,081	0	-		-	Common Stock
Stephen S. Galliker	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	26 Mar 2010	15,000	10,000	-		-	Common stock
Sanford J. Hillsberg	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	26 Mar 2010	25,000	6,000	-		-	Common Stock
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2010	50,000	50,000	-		-	Stock Option
Noah D. Beerman	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2010	5,407	5,407	-		-	Common Stock
Pamela Pavco	VP of Pharmaceutical Devlpmt.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2010	6,377	6,377	-		-	Common Stock
Dmitry Samarsky	VP, Technology Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2010	4,081	4,081	-		-	Common Stock
Ramani Varanasi	VP Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2010	5,558	5,558	-		-	Common Stock
Anastasia Khvorova	Chief Science Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2010	7,506	7,506	-		-	Common Stock
Konstantinos Andrikopoulos	VP, Legal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2010	5,750	5,750	-		-	Common Stock
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	50,000	50,000	-		-	Stock Option
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	50,000	50,000	-		-	Stock Option
Noah D. Beerman	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	5,792	5,792	-		-	Stock Option
Mark J. Ahn	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	50,000	50,000	-		-	Stock Option
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	50,000	50,000	-		-	Stock Option
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	50,000	50,000	-		-	Stock Option
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	50,000	50,000	-		-	Stock Option
Pamela Pavco	VP of Pharmaceutical Devlpmt.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	28,054	28,054	-		-	Stock Option
Dmitry Samarsky	VP, Technology Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	18,121	18,121	-		-	Stock Option
Ramani Varanasi	VP Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	17,628	17,628	-		-	Stock Option
Anastasia Khvorova	Chief Science Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	27,182	27,182	-		-	Stock Option
Konstantinos Andrikopoulos	VP, Legal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	24,686	24,686	-		-	Stock Option
Amy Tata	Principle Acctg Officer & Cont	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2010	12,081	12,081	-		-	Stock Option
Noah D. Beerman	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2009	350,000	350,000	-		-	Stock Option
Steven A. Kriegsman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Oct 2009	5,000	5,000	-		-	Common Stock
Stephen S. Galliker	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Oct 2009	15,000	25,000	-		-	Common Stock
Sanford J. Hillsberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Oct 2009	25,000	31,000	-		-	Common Stock
Rudolph Nisi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Oct 2009	3,500	3,500	-		-	Common Stock
Anastasia Khvorova	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Sep 2009	18,758	18,758	-		-	Stock Option
Anastasia Khvorova	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Sep 2009	81,242	81,242	-		-	Stock Option
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Aug 2009	8,990	0	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Jul 2009	1,170	10,711	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Jul 2009	1,723	8,988	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	1,800	14,781	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	2,900	11,881	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	25 Jun 2009	1,500	21,181	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	25 Jun 2009	4,600	16,581	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Jun 2009	500	23,281	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Jun 2009	600	22,681	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Jun 2009	1,700	24,981	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Jun 2009	1,200	23,781	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Jun 2009	1,201	28,081	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Jun 2009	1,400	26,681	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Jun 2009	1,200	29,682	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Jun 2009	400	29,282	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Jun 2009	1,100	33,382	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Jun 2009	2,500	30,882	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	09 Jun 2009	3,700	35,982	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	09 Jun 2009	1,500	34,482	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Jun 2009	800	43,682	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Jun 2009	4,000	39,682	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Jun 2009	2,400	47,082	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Jun 2009	2,600	44,482	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Jun 2009	7,000	55,566	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Jun 2009	6,084	49,482	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	28 May 2009	1,700	64,866	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	28 May 2009	2,300	62,566	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	26 May 2009	4,800	66,566	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 May 2009	700	71,366	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 May 2009	3,513	73,809	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 May 2009	1,743	72,066	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 May 2009	5,500	81,373	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 May 2009	4,051	77,322	-		-	Common
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 May 2009	2,800	89,173	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 May 2009	2,300	86,873	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Apr 2009	1,700	97,473	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Apr 2009	5,500	91,973	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Apr 2009	1,700	100,373	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Apr 2009	1,200	99,173	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Apr 2009	2,800	104,073	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Apr 2009	2,000	102,073	-		-	Common Stock
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Apr 2009	50,000	50,000	-		-	Stock Option
Richard Chin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Apr 2009	50,000	50,000	-		-	Stock Option
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Apr 2009	1,900	107,873	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Apr 2009	1,000	106,873	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Apr 2009	3,100	110,073	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Apr 2009	300	109,773	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Apr 2009	2,400	116,073	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Apr 2009	2,900	113,173	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Apr 2009	1,700	124,773	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Apr 2009	6,300	118,473	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	09 Apr 2009	1,200	126,473	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	08 Apr 2009	2,400	127,673	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	06 Apr 2009	2,409	130,873	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	06 Apr 2009	800	130,073	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	02 Apr 2009	3,100	134,682	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	02 Apr 2009	1,400	133,282	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	31 Mar 2009	6,033	140,392	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	31 Mar 2009	2,610	137,782	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Mar 2009	4,209	149,025	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Mar 2009	600	148,425	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Mar 2009	1,100	147,325	-		-	Common Stock
Ramani Varanasi	VP, Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Mar 2009	14,760	14,760	-		-	Stock Option
Ramani Varanasi	VP, Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Mar 2009	85,240	100,000	-		-	Stock Option
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	25 Mar 2009	1,500	154,934	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	25 Mar 2009	1,700	153,234	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Mar 2009	5,447	157,234	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Mar 2009	800	156,434	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Mar 2009	2,000	164,281	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Mar 2009	1,600	162,681	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Mar 2009	2,600	169,681	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Mar 2009	3,400	166,281	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Mar 2009	900	146,425	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	12 Mar 2009	1,300	174,684	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	12 Mar 2009	2,401	172,281	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 Mar 2009	7,400	178,684	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 Mar 2009	2,700	175,984	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	06 Mar 2009	1,300	190,584	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	06 Mar 2009	4,500	186,084	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Mar 2009	2,100	191,884	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2009	3,000	206,584	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2009	1,800	204,784	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2009	400	204,384	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2009	1,300	203,084	-		-	Commpn Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2009	4,700	198,384	-		-	Common Stock
Steven A. Kriegsman	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2009	2,900	195,484	-		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

34.78% Fall from 52W High

Insider Trading disclosures for SELLAS Life Sciences Group Inc

The latest disclosure was made by Angelos M. Stergiou in SELLAS Life Sciences Group Inc where a trade of 257,000 Common Stock done was reported to US exchanges on Jan. 10, 2025.

Screeners based on Insider Trading and SAST parameters